An electronic infrastructure for research and treatment of the thalassemias and other hemoglobinopathies: The Euro-Mediterranean ITHANET project

Hemoglobin

Volumn 33, Issue 3-4, 2009, Pages 163-176

  Lederer, Carsten W ^a   Basak, A Nazli ^b   Aydinok, Yesim ^c   Christou, Soteroula ^d   El Beshlawy, Amal ^e   Eleftheriou, Androulla ^f   Fattoum, Slaheddine ^g   Felice, Alex E ^h   Fibach, Eitan ⁱ   Galanello, Renzo ^j   Gambari, Roberto ^k   Gavrila, Lucian ^l   Giordano, Piero C ^m   Grosveld, Frank ⁿ   Hassapopoulou, Helen ^o   Hladka, Eva ^p   Kanavakis, Emmanuel ^q   Locatelli, Franco ^r   Old, John ^s   Patrinos, George P ^t   Romeo, Giovanni ^u   Taher, Ali ^v   Traeger Synodinos, Joanne ^q   Vassiliou, Panayiotis ^a   Villegas, Ana ^w   Voskaridou, Ersi ^x   Wajcman, Henri ^y   Zafeiropoulos, Anastasios ^z   Kleanthous, Marina ^a   more..

^a CYPRUS INSTITUTE OF NEUROLOGY AND GENETICS   (Cyprus)

^b BOGAZICI UNIVERSITY   (Turkey)

^c EGE UNIVERSITY   (Turkey)

^d NICOSIA GENERAL HOSPITAL   (Cyprus)

^e CAIRO UNIVERSITY   (Egypt)

^f Thalassaemia International Federation   (Cyprus)

^g CHILDREN S HOSPITAL   (Tunisia)

^h UNIVERSITY OF MALTA   (Malta)

ⁱ HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^j UNIVERSITY OF CAGLIARI   (Italy)

^k UNIVERSITY OF FERRARA   (Italy)

^l UNIVERSITY OF BUCHAREST   (Romania)

^m LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁿ ERASMUS MEDICAL CENTER   (Netherlands)

^o AHEPA UNIVERSITY HOSPITAL   (Greece)

^p CESNET   (Czech Republic)

^q UNIVERSITY OF ATHENS   (Greece)

^r FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^s OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^t Asclepion Genetics   (Switzerland)

^u European Genetic Foundation   (Italy)

^v Chronic Care Center Hazmieh   (Lebanon)

^w HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^x LAIKO GENERAL HOSPITAL   (Greece)

^y INSERM   (France)

^z Greek Research and Technology Network SA   (Greece)

more..

Author keywords

Community networks; Database; Hemoglobinopathies; International cooperation; Thalassemia

Indexed keywords

HEMOGLOBIN;

ARTICLE; CLINICAL PROTOCOL; COMMUNITY; COMPUTER NETWORK; COMPUTER PROGRAM; DATA BASE; EGYPT; EUROPE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE PLANNING; HEMOGLOBINOPATHY; HUMAN; INTERNATIONAL COOPERATION; INTERNET; ISRAEL; LEBANON; MEDICAL ETHICS; MEDICAL INFORMATION SYSTEM; MEDICAL RESEARCH; PRENATAL DIAGNOSIS; PROBLEM SOLVING; RESOURCE MANAGEMENT; SCREENING TEST; THALASSEMIA; TUNISIA; TURKEY (REPUBLIC); VIDEOCONFERENCING;

EUROPE; GEOGRAPHY; HEMOGLOBINOPATHIES; HUMANS; INFORMATION SYSTEMS; INTERNATIONAL COOPERATION; INTERNET; MEDITERRANEAN REGION; RESEARCH; THALASSEMIA;

EID: 68849115226     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.1080/03630260903089177     Document Type: Article

References (57)

1. Spallek H, Butler BS, Schleyer TK, et al. Supporting emerging disciplines with e-communities: Needs and benefits. J Med Internet Res. 2008;10(2):e19.
2. Williams F, Boren SA. The role of the electronic medical record (EMR) in care delivery development in developing countries: A systematic review. Inform Prim Care. 2008;16(2):139-145.
3. Peterson K. Practice-based primary care research-translating research into practice through advanced technology. Fam Pract. 2006;23(2):149-150.
4. Scales DC, Adhikari NK. Lost in (knowledge) translation: "All breakthrough, no follow through"? Crit Care Med. 2008;36(5):1654-1655.
5. Roberts I, de Montalembert M. Sickle cell disease as a paradigm of immigration hematology: New challenges for hematologists in Europe. Haematologica. 2007;92(7):865-871. (Pubitemid 350144231)
6. Higgs DR, Vernimmen D, Wood B. Long-range regulation of α-globin gene expression. Adv Genet. 2008;61:143-173.
7. Palstra RJ, de Laat W, Grosveld F. β-Globin gegulation and long-range interactions. Adv Genet. 2008;61:107-112.
8. Thein SL. Genetic modifiers of β-Thalassaemia. Haematologica. 2005;90(5):649-660.
9. Pasvol G, Weatherall DJ, Wilson RJ. Cellular mechanism for the protective effect of Haemoglobin S against P. falciparum malaria. Nature. 1978; 274(5672):701-703. (Pubitemid 8405068)
10. Modiano D, Luoni G, Sirima BS, et al. Haemoglobin C protects against clinical Plasmodium falciparum malaria. Nature. 2001;414(6861):305-308. (Pubitemid 33097806)
11. +- Thalassemia protects African children from severe malaria. Blood. 2004;104(7):2003-2006.
12. Chotivanich K, Udomsangpetch R, Pattanapanyasat K, et al. Hemoglobin E: A balanced polymorphism protective against high parasitemias and thus severe P falciparum malaria. Blood. 2002;100(4):1172-1176. (Pubitemid 34864268)
13. van Baal S, Kaimakis P, Phommarinh M, et al. FINDbase: A relational database recording frequencies of genetic defects leading to inherited disorders worldwide. Nucleic Acids Res. 2007;35(Database issue):D690-D695. (Pubitemid 46056293)
14. Metcalfe SA, Barlow-Stewart K, Campbell J, Emery J. Genetics and blood - haemoglobinopathies and clotting disorders. Aust Fam Phys. 2007;36(10):812-819.
15. Vichinsky E. Hemoglobin E syndromes. Hematol Am Soc Hematol Educ Program. 2007;2007:79-83.
16. Flint J, Harding RM, Boyce AJ, Clegg JB. The population genetics of the haemoglobinopathies. Baillieres Clin Haematol. 1998;11(1):1-51.
17. Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: An increasing global health problem. Bull World Health Organ. 2001;79(8):704-712.
18. Modell B, Darlison M, Birgens H, et al. Epidemiology of haemoglobin disorders in Europe: An overview. Scand J Clin Lab Invest. 2007;67(1):39-69. (Pubitemid 46252846)
19. Dickerhoff R, Kulozik AE, Kohne E. [Monitoring pregnant patients from risk countries with sickle cell disease and thalassemia. Clinical aspects, screening and prenatal diagnosis]. Geburtshilfe Frauenheilkd. 1993;53(4):215-221.
20. Shafer FE, Lorey F, Cunningham GC, Klumpp C, Vichinsky E, Lubin B. Newborn screening for sickle cell disease: 4 years of experience from California's newborn screening program. J Pediatr Hematol Oncol. 1996;18(1):36-41. (Pubitemid 26048522)
21. Lau YL, Chan LC, Chan YY, et al. Prevalence and genotypes of α- and β-thalassemia carriers in Hong Kong-implications for population screening. N Engl J Med. 1997;336(18):1298-1301.
22. Modell B, Harris R, Lane B, et al. Informed choice in genetic screening for thalassaemia during pregnancy: Audit from a national confidential inquiry. BMJ. 2000;320(7231):337-341. (Pubitemid 30083182)
23. Harteveld CL, van Helden WC, Boxma GL, et al. Hb Zoetermeer: A new mutation on the α2 gene inducing an Ala→Ser substitution at codon 21 is possibly associated with a mild thalassemic phenotype. Hemoglobin. 2007;31(3):325-332.
24. Vichinsky EP. Changing patterns of thalassemia worldwide. Ann NY Acad Sci. 2005;1054:18-24.
25. Chadwick R, ten Have H, Husted J, et al. Genetic screening and ethics: European perspectives. J Med Philos. 1998;23(3):255-273.
26. Locock L, Kai J. Parents' experiences of universal screening for haemoglobin disorders: Implications for practice in a new genetics era. Br J Gen Pract. 2008;58(548):161-168.
27. Aluoch JR, De Geus A, Goudsmit R. Clinical and laboratory features of sickle cell disease in the Netherlands. Trop Geogr Med. 1988;40(1):7-12. (Pubitemid 18121165)
28. Lorey FW, Arnopp J, Cunningham GC. Distribution of hemoglobinopathy variants by ethnicity in a multiethnic state. Genet Epidemiol. 1996;13(5):501-512. (Pubitemid 26359326)
29. Hickman M, Modell B, Greengross P, Chapman C, Layton M, Falconer S, et al. Mapping the prevalence of sickle cell and b thalassaemia in England: Estimating and validating ethnic-specific rates. Br J Haematol. 1999;104(4):860-867. (Pubitemid 29143509)
30. Davies SC, Cronin E, Gill M, Greengross P, Hickman M, Normand C. Screening for sickle cell disease and thalassaemia: A systematic review with supplementary research. Health Technol Assess. 2000;4(3):i-v, 1-99. (Pubitemid 30223958)
31. Angastiniotis MA, Hadjiminas MG. Prevention of thalassaemia in Cyprus. Lancet. 1981;1(8216):369-371.
32. Telfer P, Coen PG, Christou S, et al. Survival of medically treated thalassemia patients in Cyprus. Trends and risk factors over the period 1980-2004. Haematologica. 2006;91(9):1187-1192.
33. Zohoun IS, Merault G, Reinette P, Rosa J. [Health policies and sickle cell disease]. Rev Prat. 1992;42(15):1873-1877.
34. Ko TM, Xu X. Molecular study and prenatal diagnosis of α- and β-thalassemias in Chinese. J Formos Med Assoc. 1998;97(1):5-15. (Pubitemid 28067841)
35. Diagne I, Diagne-Gueye ND, Signate-Sy H, et al. [Management of children with sickle cell disease in Africa: Experience in a cohort of children at the Royal Albert Hospital in Dakar]. Med Trop (Mars). 2003;63(4-5):513-520.
36. Masmas TN, Garly ML, Lisse IM, Rodriques A, Petersen PT, Birgens H. Inherited hemoglobin disorders in Guinea-Bissau, West Africa: A population study. Hemoglobin. 2006;30(3):355-364. (Pubitemid 44091797)
37. De Montalembert M, Tshilolo L. [Is therapeutic progress in the management of sickle cell disease applicable in sub-Saharan Africa?]. Med Trop (Mars). 2007;67(6):612-616.
38. Borgna-Pignatti C. Thalassemia. A few new tiles in a large mosaic. Haematologica. 2006;91(9):1159-1161. (Pubitemid 44408423)
39. Eleftheriou A. The role of the Thalassaemia International Federation in health professionals' education. Pediatr Endocrinol Rev. 2004;2(Suppl. 2):242-244.
40. Weatherall D, Hofman K, Rodgers G, Ruffin J, Hrynkow S. A case for developing North-South partnerships for research in sickle cell disease. Blood. 2005;105(3):921-923. (Pubitemid 40170855)
41. European Genetics Foundation. (2009). http://www.eurogene.org/portale/ index.php.
42. Archived at: http://www.webcitation.org/5eBoKb8TS [accessed January 29, 2009].
43. Holub P, Hladka E, Prochazka M, Liska M. Secure and pervasive collaborative platform for medical applications. Stud Health Technol Inform. 2007;126:229-238.
44. Telethra, Inc. (2009). OpenVPN. http://www.openvpn.net/.
45. Archived at: http://www.webcitation.org/5eBnwUInS [accessed January 29, 2009].
46. The EUMEDCONNECT Network. (2009). http://www.eumedconnect.net.
47. Archived at: http://www.webcitation.org/5eBnyqPIt [accessed January 29, 2009].
48. The Ithanet Consortium. (2009). ITHANET. http://project.ithanet.eu.
49. Archived at: http://www.webcitation.org/5eBns77ZT [accessed January 29, 2009].
50. The ITHANET Consortium. (2009). The ITHANET Portal. http://www.ithanet. eu.
51. Archived at: http://www.webcitation.org/5eBnlBi5T [accessed January 29, 2009].
52. The Access Grid Community. (2009). http://www.accessgrid.org.
53. Archived at: http://www.webcitation.org/5eBntqNm4 [accessed January 29, 2009].
54. Thalassaemia International Federation. (2009). http://www.thalassaemia. org.cy.
55. Archived at: http://www.webcitation.org/5eBnXay4B [accessed January 29, 2009].
56. Kalokairinou EM. The experience of β-thalassaemia and its prevention in Cyprus. Med Law. 2007;26(2):291-307.
57. Hoedemaekers R, ten Have H. Geneticization: the Cyprus paradigm. J Med Philos. 1998;23(3):274-287.